Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. This role works collaboratively with Pharmacovigilance (PV), Medical Safety, and cross-functional stakeholders to manage the benefit-risk profile of products, ensure patient safety, and support regulatory compliance.